Treatment patterns and best response in a contemporary cohort of patients with relapsed/refractory chronic lymphocytic leukemia with 17p deletion

被引：0
|
作者：
Lamanna, Nicole
Hurst, Deborah
Latremouille-Viau, Dominick
Ionescu-Ittu, Raluca
Guerin, Annie
Yim, Yeun Mi
Reyes, Carolina
机构：
[1] Herbert Irving Comprehens Canc Ctr, Hematol Malignancies Sect, New York, NY USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] Anal Grp Inc, Montreal, PQ, Canada
来源：
LEUKEMIA & LYMPHOMA | 2015年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
175
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [41] Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
    Shustik, C.
    Bence-Bruckler, I.
    Delage, R.
    Owen, C. J.
    Toze, C. L.
    Coutre, S.
    ANNALS OF HEMATOLOGY, 2017, 96 (07) : 1185 - 1196
  • [42] A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib
    Mato, Anthony R.
    Tang, Boxiong
    Azmi, Soraya
    Yang, Keri
    Zhang, Xiaojuan
    Stern, Jennifer C.
    Hedrick, Eric
    Huang, Jane
    Sharman, Jeff P.
    HAEMATOLOGICA, 2022, 107 (11) : 2630 - 2640
  • [43] Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
    C. Shustik
    I. Bence-Bruckler
    R. Delage
    C. J. Owen
    C. L. Toze
    S. Coutre
    Annals of Hematology, 2017, 96 : 1185 - 1196
  • [44] Optimizing Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Mato, Anthony
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (5.5): : 581 - 583
  • [45] LARGE SCALE, REAL-WORLD RESULTS ON IBRUTINIB FOR 428 FRENCH PATIENTS WITH 17P DELETION OR RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA INCLUDED IN A TEMPORARY AUTHORIZATION FOR USE (ATU) PROGRAM
    Ysebaert, L.
    Aurran-Schleinitz, T.
    Dartigeas, C.
    Dilhuydy, M. S.
    Feugier, P.
    Michallet, A. S.
    Tournilhac, O.
    Dupuis, J.
    Sinet, P.
    Albrecht, C.
    Cymbalista, F.
    HAEMATOLOGICA, 2016, 101 : 57 - 58
  • [46] Changing The Treatment Paradigm For Previously Treated Chronic Lymphocytic Leukemia Patients With Del(17p) Karyotype
    Stephens, Deborah M.
    Stark, Amy
    Jones, Jeffrey A.
    Woyach, Jennifer A.
    Maddocks, Kami
    Jaglowski, Samantha M.
    Andritsos, Leslie A.
    Flynn, Joseph M. M.
    Grever, Michael R.
    Lozanski, Gerard
    Johnson, Amy J.
    Muthusamy, Natarajan
    Heerema, Nyla A.
    Byrd, John C.
    BLOOD, 2013, 122 (21)
  • [47] DOSE DENSE HIGH DOSE METHYLPREDNISOLONE (HDMP) AND RITUXIMAB (RTX) ARE EFFECTIVE IN RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH 17P DELETION (17P DEL) / TP53 MUTATION
    Pileckyte, R.
    Valceckiene, V.
    Zvirblis, T.
    Griskevicius, L.
    HAEMATOLOGICA, 2012, 97 : 525 - 526
  • [48] VENETOCLAX IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: OUTCOME AND MINIMAL RESIDUAL DISEASE FROM THE FULL POPULATION OF THE PIVOTAL M13-982 TRIAL
    Stilgenbauer, S.
    Chyla, B.
    Eichhorst, B.
    Schetelig, J.
    Munir, T.
    Hillmen, P.
    Seymour, J. F.
    Roberts, A. W.
    Coutre, S.
    Jurczak, W.
    Mulligan, S. P.
    Puvvada, S.
    Wendtner, C-M
    Davids, M.
    Boeettcher, S.
    Cerri, E.
    Zhou, L.
    Popovic, R.
    Poteracki, M.
    Arzt, J.
    Kim, S. Y.
    Verdugo, M.
    Bhathena, A.
    Wierda, W.
    Hallek, M.
    HAEMATOLOGICA, 2017, 102 : 311 - 312
  • [49] Overexpression of Galectin-3 in Chronic Lymphocytic Leukemia Is Associated With 17p Deletion: A Short Report
    Michalova, Zuzana
    Coma, Matus
    Kicova, Miroslava
    Gabzdilova, Juliana
    Dedinska, Kinga
    Guman, Tomas
    Hajikova, Martina
    Veselinyova, Dominika
    Giertlova, Maria
    Gal, Peter
    Sarissky, Marek
    ANTICANCER RESEARCH, 2019, 39 (06) : 2805 - 2810
  • [50] Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocyticleukaemia treated with ibrutinib from 3 clinical trials
    Jones, Jeffrey
    Mato, Anthony
    Coutre, Steven
    Byrd, John C.
    Furman, Richard R.
    Hillmen, Peter
    Osterborg, Anders
    Tam, Constantine
    Stilgenbauer, Stephan
    Wierda, William G.
    Heerema, Nyla A.
    Eckert, Karl
    Clow, Fong
    Zhou, Cathy
    Chu, Alvina D.
    James, Danelle F.
    O'Brien, Susan M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (04) : 504 - 512
12345